Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 1
2014 3
2015 5
2016 4
2017 8
2018 9
2019 5
2020 11
2021 12
2022 12
2023 11
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
In Reply to Murgic and Chung.
van Son MJ, Peters M, Moerland MA, van der Voort van Zyp JRN. van Son MJ, et al. Among authors: van der voort van zyp jrn. Int J Radiat Oncol Biol Phys. 2021 Jun 1;110(2):618-619. doi: 10.1016/j.ijrobp.2021.01.021. Int J Radiat Oncol Biol Phys. 2021. PMID: 33989587 No abstract available.
In response to Grivas et al.
van den Berg I, Savenije MHF, Teunissen FR, van de Pol SMG, Rasing MJA, van Melick HHE, Brink WM, de Boer JCJ, van den Berg CAT, van der Voort van Zyp JRN. van den Berg I, et al. Among authors: van der voort van zyp jrn. Phys Imaging Radiat Oncol. 2023 Nov 17;28:100514. doi: 10.1016/j.phro.2023.100514. eCollection 2023 Oct. Phys Imaging Radiat Oncol. 2023. PMID: 38077273 Free PMC article. No abstract available.
Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
Aluwini SS, Mehra N, Lolkema MP, Oprea-Lager DE, Yakar D, Stoevelaar H, van der Poel H; Dutch Oligometastatic Prostate Cancer Working Group; Busstra M, de Jong IJ, de Reijke T, de Vries K, Heijmink S, Jenster G, Klaver S, Kneppers J, Lavalaye J, Leyten G, Moonen L, Nagaraj J, Noordzij W, Osanto S, Oving I, Schaake E, Scheenen T, Schoots I, Sedelaar M, Somford D, van den Berkmortel F, van der Hulle T, van der Voort van Zyp J, van Leeuwen P, van Moorselaar J, van Oort I, Vogel W, Westgeest H. Aluwini SS, et al. Among authors: van der voort van zyp j. Eur Urol Oncol. 2020 Apr;3(2):231-238. doi: 10.1016/j.euo.2019.07.010. Epub 2019 Aug 8. Eur Urol Oncol. 2020. PMID: 31401014
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial.
De Cock L, Draulans C, Pos FJ, Isebaert S, De Roover R, van der Heide UA, Smeenk RJ, Kunze-Busch M, van der Voort van Zyp J, de Boer H, Kerkmeijer LGW, Haustermans K. De Cock L, et al. Among authors: van der voort van zyp j. Radiother Oncol. 2023 Aug;185:109713. doi: 10.1016/j.radonc.2023.109713. Epub 2023 May 11. Radiother Oncol. 2023. PMID: 37178932 Clinical Trial.
Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).
van der Sar ECA, Braat AJAT, van der Voort-van Zyp JRN, van der Veen BS, van Leeuwen PJ, de Vries-Huizing DMV, Hendrikx JMA, Lam MGEH, Vogel WV. van der Sar ECA, et al. Among authors: van der voort van zyp jrn. BMC Cancer. 2023 Mar 23;23(1):268. doi: 10.1186/s12885-023-10725-5. BMC Cancer. 2023. PMID: 36959540 Free PMC article. Clinical Trial.
75 results